Cellebrite DI Ltd.
NASDAQ:CLBT
18.49 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 189.517 | 87.645 | 145.973 | 128.709 | 76.546 |
| Short Term Investments
| 113.406 | 95.978 | 35.592 | 108.928 | 123.706 |
| Cash and Short Term Investments
| 302.923 | 183.623 | 181.565 | 237.637 | 200.252 |
| Net Receivables
| 77.269 | 78.761 | 67.505 | 66.324 | 44.237 |
| Inventory
| 10.538 | 10.176 | 6.511 | 4.754 | 3.96 |
| Other Current Assets
| 25.802 | 17.085 | 12.818 | 2.957 | 1.655 |
| Total Current Assets
| 416.532 | 295.931 | 273.212 | 324.27 | 261.883 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 30.156 | 32.912 | 16.756 | 16.106 | 14.824 |
| Goodwill
| 26.829 | 26.829 | 26.829 | 9.463 | 0 |
| Intangible Assets
| 10.594 | 11.254 | 11.228 | 6.611 | 0 |
| Goodwill and Intangible Assets
| 37.423 | 38.083 | 38.057 | 16.074 | 0 |
| Long Term Investments
| 28.859 | 22.125 | 0 | 0 | 0 |
| Tax Assets
| 14.536 | 12.511 | 9.8 | 7.372 | 3.086 |
| Other Non-Current Assets
| 12.891 | 1.731 | 1.958 | 0.565 | 0.447 |
| Total Non-Current Assets
| 123.865 | 107.362 | 66.571 | 40.117 | 18.357 |
| Total Assets
| 540.397 | 403.293 | 339.783 | 364.387 | 280.24 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 8.282 | 4.612 | 9.546 | 4.727 | 5.36 |
| Short Term Debt
| 4.972 | 5.003 | 0 | 0 | 0 |
| Tax Payables
| 0.833 | 2.853 | 8.235 | 6.61 | 1.272 |
| Deferred Revenue
| 196.587 | 152.709 | 122.983 | 106.102 | 69.792 |
| Other Current Liabilities
| 43.983 | 45.453 | 54.044 | 48.553 | 24.008 |
| Total Current Liabilities
| 253.824 | 207.777 | 186.573 | 159.382 | 99.16 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 9.157 | 10.353 | -2.676 | -2.757 | 0 |
| Deferred Revenue Non-Current
| 47.098 | 42.173 | 36.426 | 33.439 | 18.928 |
| Deferred Tax Liabilities Non-Current
| 7.512 | 5.532 | 2.676 | 2.757 | 0 |
| Other Non-Current Liabilities
| 188.594 | 63.593 | 190.133 | 107.762 | 103.324 |
| Total Non-Current Liabilities
| 252.361 | 121.651 | 226.559 | 141.201 | 122.252 |
| Total Liabilities
| 506.185 | 329.428 | 413.132 | 300.583 | 221.412 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 101.205 | 101.205 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| 118.143 | 199.243 | 78.436 | 28.342 | 32.561 |
| Accumulated Other Comprehensive Income/Loss
| 1.05 | 0.331 | 1.372 | 1.321 | 0.804 |
| Other Total Stockholders Equity
| -84.981 | -125.709 | -153.157 | -67.064 | -75.742 |
| Total Shareholders Equity
| 34.212 | 73.865 | -73.349 | 63.804 | 58.828 |
| Total Equity
| 34.212 | 73.865 | -73.349 | 63.804 | 58.828 |
| Total Liabilities & Shareholders Equity
| 540.397 | 403.293 | 339.783 | 364.387 | 280.24 |